III

3I Group PLC

III.LSE 3i.com + Research + Basket
ISIN GB00B1YW4409
Employees 223
Phone 44 20 7975 3131
Fiscal year end March
Address 1 Knightsbridge, London, United Kingdom, SW1X 7LX
24.48
+0.16 (+0.66%)
GBP · LSE
52-week range
17.87
42.63
Trading at 27% of the 52-week range
Market Cap
24.82B
P/E Ratio
4.54
Forward P/E
7.69
Book Value
30.34
Div. Yield
3.47%
% Institutions
78.49%
% Insiders
2.04%

1 Year

-43.1%

3 Year

+36.3%

10 Year

+393.9%
Description

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer and private label, software and service, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; private label CMO and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, personalized medicine, pharmaceuticals and biotechnology including specialty pharma, generics or OTC, drug delivery, and animal health; healthcare services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in co

Actions

Add an action for III.LSE, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Simon Alexander Borrows CEO & Member of Board of Directors 1959
Mr. James Graham Hatchley M.B.E. Group Finance Director & Member of Board of Directors 1967
Ms. Jasi Hari Halai COO & Board of Directors 1978
Mr. Robert K. Collins Managing Partner & Head of North American Infrastructure 1970
Ms. Silvia Santoro Group Investor Relations & Sustainability Strategy Director NA
Mr. Kevin John Dunn General Counsel & Company Secretary 1963
Mr. John Paul Decesare Director of Group Compliance NA
Ms. Kathryn van der Kroft Group Communications Director NA
Mr. Julien Marie Chief Human Resources Officer NA
Mr. Alastair Richardson Head of Legal NA

Financial Highlights

▼
Market Cap: $24.82B
EBITDA: $5.45B
P/E Ratio: $4.54
Book Value: $30.34
Dividend/Share: $0.85
Dividend Yield: 3.47%
Earnings/Share: $5.39
Profit Margin: 94.84%
Operating Margin: 97.19%
ROA (TTM): 11.66%
ROE (TTM): 19.08%
Revenue (TTM): $5.58B
Revenue/Share (TTM): $5.69
Earnings Growth (YOY): -35.00%
Revenue Growth (YOY): -33.40%

Valuation Metrics

Enterprise Value: $25.38B
Trailing P/E: 4.54
Forward P/E: 7.69

Shares Statistics

Shares Outstanding: 1.01B
Shares Float: 939.71M
% Insiders: 2.04%
% Institutions: 78.49%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$5.58B
Cost of Goods Sold
adjust
$-5.00M
Gross Profit
subtotal
$5.58B
SG&A
adjust
$-59.00M
Other Operating Expense
adjust
$-75.00M
Operating Income
subtotal
$5.45B
Other / Non-Operating Items
adjust
$-154.00M
Net Income
subtotal
$5.29B

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about III.LSE!